SCHEMBL4474239

SCHEMBL4474239

CC(C)(C)OC(=O)N1CCC(N2CCN(C(=O)O)CC2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.50
GPR119 Q8TDV5 3/20 0.48
RECQL P46063 1/20 0.48
EPHX1 P07099 1/20 0.48
USP2 O75604 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
ALDH1A1 P00352 2/20 0.45
TP53 P04637 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
MAPT P10636 2/20 0.44
NPC1 O15118 1/20 0.44
MAPK1 P28482 1/20 0.44
HTT P42858 1/20 0.44
RAB9A P51151 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
KDM4E B2RXH2 2/20 0.44
ACACB O00763 1/20 0.44
ACACA Q13085 1/20 0.44
THRB P10828 1/20 0.44
PTPN2 P17706 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21071183 0.91 HPGD (0.44) HPGDGPR119RECQLEPHX1USP2
SCHEMBL63877 0.89 USP2 (0.53) HPGDGPR119RECQLEPHX1USP2
SCHEMBL1546995 0.88 HPGD (0.50) HPGDGPR119RECQLEPHX1USP2
SCHEMBL21871865 0.88 HPGD (0.50) HPGDGPR119RECQLEPHX1USP2
SCHEMBL4987189 0.86 HPGD (0.51) HPGDGPR119RECQLEPHX1USP2
SCHEMBL12564551 0.86 L3MBTL1 (0.48) HPGDGPR119RECQLEPHX1USP2
SCHEMBL26101858 0.86 NR1H2 (0.45) HPGDGPR119RECQLEPHX1USP2
SCHEMBL994288 0.85 HPGD (0.58) HPGDGPR119RECQLEPHX1USP2
SCHEMBL17128329 0.85 HPGD (0.62) HPGDGPR119RECQLEPHX1USP2
SCHEMBL1971010 0.85 EPHX1 (0.55) HPGDGPR119RECQLEPHX1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7538111-B2 Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain LABORATOIRES FOURNIER S.A. (FR) 2009-05-26 US disclosed
CN-101198590-A Novel pyridine derivative and pyrimidine derivative (3) EISAI R&D MAN CO LTD (JP) 2008-06-11 CN disclosed
US-20060178360-A1 Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain LABORATOIRES FOURNIER S.A. (FR) 2006-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060178360-A1 Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain LTB4R2, BDKRB2, TBXA2R HPGD 28/4885GPR119 2689/4885RECQL 733/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.